Table 5.
Risk assessment |
||||||
Benign (%) | Very low malignant potential (%) | Low malignant potential (%) | Low moderate malignant potential (%) | Malignant (%) | P | |
KIT mutation | ||||||
Positive | 10.5 | 10.5 | 21.1 | 57.9 | 0.003 | |
Negative | 63.6 | 9.1 | 18.2 | 9.1 | ||
Exon 9 | 33.3 | 66.7 | 0.036 | |||
Exon 11 | 12.5 | 6.3 | 25 | 56.3 | ||
PDGFRA mutation | ||||||
Positive | NS | |||||
Negative | 50 | 50 |